Chart review of diagnostic methods, baseline characteristics and symptoms for European patients with pancreatic cancer

To survey European physicians managing patients with metastatic pancreatic ductal adenocarcinoma (PDAC) and understand differences in baseline characteristics, diagnostic methods, symptoms and co-morbidities. Patient record inclusion criteria were: ≥18 years old, metastatic PDAC diagnosis and comple...

Full description

Saved in:
Bibliographic Details
Published in:Future oncology (London, England) England), 2021-05, Vol.17 (15), p.1843-1854
Main Authors: Carrato, Alfredo, Melisi, Davide, Prager, Gerald, Westphalen, Christoph B, Ferreras, Anabel, D'Esquermes, Nathalie, Taieb, Julien, Mercadé, Teresa M
Format: Article
Language:English
Subjects:
co-morbid conditions
metastatic disease
pancreatic ductal adenocarcinoma
PDAC
real-world data
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To survey European physicians managing patients with metastatic pancreatic ductal adenocarcinoma (PDAC) and understand differences in baseline characteristics, diagnostic methods, symptoms and co-morbidities. Patient record inclusion criteria were: ≥18 years old, metastatic PDAC diagnosis and completion of first-line treatment between July 2014 and January 2016. Records were grouped by patient age, gender and primary tumor location. Records (n = 2565) were collected from nine countries. Baseline characteristics varied between subgroups. Computed tomography was the most frequently used diagnostic technique. Symptoms at diagnosis included abdominal and/or mid-back pain (72% of patients) and weight loss (61.5%). Co-morbidities varied with patient age. Greater awareness of symptoms, diagnostic methods and co-morbidities present at PDAC diagnosis may support better patient management decisions.
ISSN:1479-6694
1744-8301
DOI:10.2217/fon-2020-0749